Cao, Z. et al. 2022. Behavior and Consequences of COVID-19-related Voluntary Disclosure: Evidence from Pharmaceutical Companies. BCP Business & Management. 31, (Nov. 2022), 378–391. DOI:https://doi.org/10.54691/bcpbm.v31i.2653.